Journal Information
Vol. 45. Issue 11.
Pages 572-573 (November 2009)
Vol. 45. Issue 11.
Pages 572-573 (November 2009)
Letters to the Editor
Full text access
Pulmonary Toxicity Associated With Cabergoline
Toxicidad pulmonar por medicamentos inducida por cabergolina
Visits
6615
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
S.J. Ellis, J.R. Cleverley, N.L. Müler.
Drug-induced lung disease, high-resolution CT findings.
AJR Am J Roentgenol, 175 (2000), pp. 1019-1024
[2.]
J.R. Graham, H.I. Suby, P.R. LeCompte, N.L. Sadowsky.
Fibrotic disorders associated with methysergide therapy for headache.
N Engl J Med, 274 (1966), pp. 359-368
[3.]
P. Pfitzenmeyer, P. Foucher, G. Dennewald, B. Chevalon, D. Debieuvre, P. Bensa, et al.
Pleuropulmonary changes induced by ergoline drugs.
Eur Respir J, 9 (1996), pp. 1013-1019
[4.]
A. Colao, G. Lombardi, L. Annunziato.
Cabergoline.
Expert Opin Pharmacother, 1 (2000), pp. 555-574
[5.]
S. Guptha, A.D. Promnitz.
Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease.
Eur J Intern Med, 16 (2005), pp. 129-131
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica